299 related articles for article (PubMed ID: 32448054)
1. Biomolecular interactions and binding dynamics of tyrosine kinase inhibitor erdafitinib, with human serum albumin.
Amir M; Qureshi MA; Javed S
J Biomol Struct Dyn; 2021 Jul; 39(11):3934-3947. PubMed ID: 32448054
[TBL] [Abstract][Full Text] [Related]
2. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies.
Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2021 Feb; 39(2):691-702. PubMed ID: 31913089
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of binding dynamics of tyrosine kinase inhibitor tepotinib, to human serum albumin, using spectroscopic and computational approach.
Amir M; Javed S
Int J Biol Macromol; 2023 Jun; 241():124656. PubMed ID: 37119913
[TBL] [Abstract][Full Text] [Related]
4. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach.
Kandandapani S; Kabir MZ; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2022 Nov; 40(18):8312-8323. PubMed ID: 33870854
[TBL] [Abstract][Full Text] [Related]
5. Understanding the binding of quinoline amines with human serum albumin by spectroscopic and induced fit docking methods.
Vennila KN; Elango KP
J Biomol Struct Dyn; 2019 Jul; 37(11):2753-2765. PubMed ID: 30052140
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the interaction between pyrogallol and human serum albumin by spectroscopic and molecular docking methods.
Roufegarinejad L; Amarowicz R; Jahanban-Esfahlan A
J Biomol Struct Dyn; 2019 Jul; 37(11):2766-2775. PubMed ID: 30052121
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic methodologies and computational simulation studies on the characterization of the interaction between human serum albumin and astragalin.
Lyu S; Wang W
J Biomol Struct Dyn; 2021 May; 39(8):2959-2970. PubMed ID: 32306829
[TBL] [Abstract][Full Text] [Related]
8. Exploring the interaction between tyrphostin 9 and human serum albumin using biophysical and computational methods.
Kandandapani S; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2020 Sep; 38(14):4134-4142. PubMed ID: 31552810
[TBL] [Abstract][Full Text] [Related]
9. Interaction and photo-induced cleavage studies of meropenem drug with human serum albumin using spectroscopic and molecular docking investigations.
Abdo Esmail SA; Shamsi M; Al-Asbahy WM
J Biomol Struct Dyn; 2019 Aug; 37(12):3282-3289. PubMed ID: 30088794
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking.
Kabir MZ; Feroz SR; Mukarram AK; Alias Z; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2016 Aug; 34(8):1693-704. PubMed ID: 26331959
[TBL] [Abstract][Full Text] [Related]
11. Biomolecular interaction of a platelet aggregation inhibitor, 3,4-methylenedioxy-β-nitrostyrene with human serum albumin: multi-spectral and computational characterization.
Kabir MZ; Roslan AA; Ridzwan NFW; Mohamad SB; Tayyab S
J Biomol Struct Dyn; 2020 Jun; 38(9):2693-2703. PubMed ID: 31271347
[TBL] [Abstract][Full Text] [Related]
12. Biophysical and computational view on the
Tayyab S; Magesvaran MKA; Kabir MZ; Ridzwan NFW; Mohamad SB
J Biomol Struct Dyn; 2021 Jul; 39(10):3565-3575. PubMed ID: 32397949
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the binding mechanism for a water-soluble Pd(II) complex containing β-amino alcohols with HSA applying experimental and computational methods.
Shahabadi N; Ghaffari L; Mardani Z; Hadidi S
J Biomol Struct Dyn; 2024 Apr; 42(7):3790-3801. PubMed ID: 37243704
[TBL] [Abstract][Full Text] [Related]
14. Multispectroscopic insight, morphological analysis and molecular docking studies of Cu
Yousuf I; Bashir M; Arjmand F; Tabassum S
J Biomol Struct Dyn; 2019 Aug; 37(12):3290-3304. PubMed ID: 30124142
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopy and molecular docking approach for investigation on the binding of nocodazole to human serum albumin.
Singh I; Luxami V; Paul K
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118289. PubMed ID: 32222625
[TBL] [Abstract][Full Text] [Related]
16. Shedding light on the bimolecular interactions of Cafaminol and human serum albumin: spectroscopic characterization and in-silico investigation.
Parvizi N; Mohammad-Aghaie D; Soltani Rad MN; Behrouz S; Alavianmehr MM
J Biomol Struct Dyn; 2022 Jul; 40(11):4893-4904. PubMed ID: 33390094
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the binding of carbendazim (fungicide) with human serum albumin: A multi-spectroscopic and molecular modelling studies.
Siddiqui MF; Khan MS; Husain FM; Bano B
J Biomol Struct Dyn; 2019 Jun; 37(9):2230-2241. PubMed ID: 30047309
[TBL] [Abstract][Full Text] [Related]
18. Probing the mechanism of interaction of metoprolol succinate with human serum albumin by spectroscopic and molecular docking analysis.
Pawar SK; Jaldappagari S
Luminescence; 2017 Sep; 32(6):942-951. PubMed ID: 28233399
[TBL] [Abstract][Full Text] [Related]
19. Insights into interaction of triazine herbicides with three kinds of different alkyl groups (simetryne, ametryn and terbutryn) with human serum albumin via multi-spectral analysis.
Yang Y; Han W; Zhang H; Qiao H; Zhang Y; Zhang Z; Wang J
Pestic Biochem Physiol; 2024 May; 201():105895. PubMed ID: 38685222
[TBL] [Abstract][Full Text] [Related]
20. Interpretation of the binding interaction between bupropion hydrochloride with human serum albumin: A collective spectroscopic and computational approach.
M M; H D R
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Feb; 209():264-273. PubMed ID: 30414575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
